The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There are two things:
- People want instant gratification and think that buying in the morning and 10x by lunch time. So, they tend to rainbow chase and buy when those who have been there have bagged or more and are thinking of selling
To make money on shares, it's common sense- do your research, buy low, believe in your investment , wait for it to go up, have a clear exit plan and you will make money
#ANA for me is a great example. It sit, wait and it's going in the right direction with very positive updates and steps forward
Agree. As soon as the dumb MP's in this country realize that substantial tax revenue can be generated on legalizing it, in a controlled way to sell from certain shops, taking out the little dealer in the process too. People are going to smoke it anyway so it just baffles me the mentality of these MP's.
I'm surprised that many are still not aware of this hidden gem waiting to erupt....
2p should be no problem from here ...that's over 100% from today's buy in price
I've bought more today and will be taking more in the next few days.
Anything under 1p = 100% profit in a very short space of time imo
We are entering a news rich period and with each RNS the SP will only move up.
M.S has already mentioned about telling the market on every detail regarding the company.
Anyone buying in now, with the amount of shares in free float, could do extremely well.
Timing is perfect to get in here
This was over 1.5p not so long ago and believe we will see a lot more than 2p May 22
We will most probably edge above 1p this week as stock is being bought up daily and cheap shares seem to have been bought up.
My take is a strong week to look forward to and I will be buying as much as I can under 1p.
2p seems more like it with what stands
GJ- I hear you and as stated this is based on conversation with other holders.
As such if the big boys want in, I could see a big pharma looking at this as a plug and play for them.
Anything is possible, but we are going in the right direction and we are getting good progress
I like your optimism MaxHS, and hope you are right!
I can certainly see 2p in sight based in a fully functional research and growing facility, so perhaps by mid 2022.
Personally I think 9-13 might be a bit optimistic as that would give an mcap of between £70-100m. I think until we get an understanding of the number of plants to be grown, the size of the harvest, the market value for the harvest, and then hence the potential revenue. Until then I think we are really shooting in the air at potential share price.
I’ll be happy if we get to 4p by early 2023 by which time we should have a better understanding of revenue potential and maybe then we’ll be able make a decent stab at a forecast of share price.
Don’t get wrong, I’m very optimistic of good progress and I don’t mean for this to come across as a downer but I try to keep myself reigned in on medium to long term forecasts until I have a better understanding of the fundamentals. That said, the one thing that gives me great confidence in ANA is the size of the shareholding of MS!
Very good day today though!
At this stage IMO the fair value would be around the 2p mark and then (based on several conversations) around the 9-13p range upon harvest
Well the news has certainly brought some life back into the share again, hopefully this is the kick in the teeth it needed.
Thanks WakoJ!
I thought it was something like that but I don't have a green thumb! But it makes sense!
They keep them separate so the males do not pollinate the female plant and then you get the flower full of resin and all the money instead of seed, it's way to tell them apart the males have balls
Balls of pollen which hang down but they males will be used in this case because they will be doing some selected breeding and they mother plants will be used to make clones from cuttings which they can use to make exact replicas of the best plant. This is a slow game but this will pay off massively in the long run get in now before we end up on elon musk next rocket to the moon haha
Well folks a bigger facility in my book represents potentially more plants and more plants equals more money!
I ts interesting how they keep the male and the female plants separate!
ANANDA DEVELOPMENTS PLC
(“Ananda” or the “Company”)
Research Facility Construction Update
Ananda, the AQSE-listed medical cannabis company creating UK-based operations to grow and provide carbon neutral, consistent, pharmaceutical quality medical cannabis for the UK and international markets, provides the following update on the construction of its research facility.
Since the Company’s update on 6 September 2021, works have continued on schedule at the medical cannabis research growing facility being developed in the UK by DJT Plants Limited (“DJT Plants”), the Company’s 50% owned subsidiary.
As previously announced the facility footprint has been increased. To provide further detail to shareholders, it now incorporates:
a dedicated growing room for female plants (which produce the resin secreting flowers used for medicinal cannabis)
a dedicated growing room for male plants (grown to pollinate the female plants)
a dedicated plant nursery
a dedicated room for mother plants (to guarantee genetic consistency of each generation of plants)
laboratory space (for trimming plants, analysing characteristics and test work)
enlarged work rooms
The facility is also being constructed to allow for thorough cleaning and to accommodate appropriate work flows and movement of plants through the work rooms. These are requirements for Good Manufacturing Practices (“GMP”) certification, which will be applied for in due course. The facility construction management team (supplied by Ananda’s partner JE Piccaver & Co (Gedney Marsh) Limited (“JEPCO”)) is well versed in all aspects of high plant care standards, as they are required in the salad leaf industry where JEPCO operates as a large-scale speciality grower. Salad leaves are not cooked before being consumed, so the team is very familiar with the required levels of hygiene, work-flow management and deep cleaning. JEPCO operates to Red Tractor standards, which were established in 2000 and which have grown to become the UK’s biggest farm and food standards scheme, covering all aspects of food safety, traceability and environmental protection. JEPCO is also accredited under Global GAP (the Global Partnership for Safe and Sustainable Agriculture) and is a Selected Grower under the Marks & Spencer Field to Fork programme.
DJT Plants holds a licence from the Home Office of the UK Government to grow >0.2% THC cannabis for research purposes.